<DOC>
	<DOCNO>NCT00771693</DOCNO>
	<brief_summary>The postprandial phase diabetic patient characterize rapid increase blood glucose level , increase platelet aggregation , LDL oxidation production thrombin . The aim study determine whether meal induced platelet activation relate post-prandial hyperglycemia , attenuate good postprandial glucose control rapidly act insulin patient T2DM .</brief_summary>
	<brief_title>Effects Insulin Treatment Postprandial Platelet Activation Patients With Non-insulin-dependent Diabetes Mellitus ( NIDDM )</brief_title>
	<detailed_description>Each patient admit fast state , 3 different occasion . Blood glucose level normalize use intravenous infusion insulin aspart , blood glucose level 6-7 mmol/l . 15 minute normalization , right standardize meal , patient give subcutaneous injection insulin aspart 0.1 U/kg , 0.2 U/kg placebo . The order injection cross study randomize blind patient investigator . The patient eat meal follow 90 minute completion meal . Blood test platelet function parameter take 3 main point : 1. glucose normalization . 2 . 15 minute glucose normalization , right meal . 3 . 90 minute meal . Platelet function evaluate flow cytometry whole blood ( P- Selectin expression , Fibrinogen binding , aggregate formation : platelet- leukocyte , platelet-platelet , platelet-monocyte ) . Agonists use platelet activation flow cytometry thromboxane analogue U46619 , ADP , collagen peptide activate GPVI . Platelet adhesion measure IMPACT cone platelet analyser .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type II Diabetes Mellitus . Antecubital forearm vein allow technically good sample platelet study . HbA1c 69 % ( MonoS method ) . Below 70 year History cardiovascular disease ; Ischemic heart disease , Stroke , Peripheral vascular disease . Acute chronic renal liver disease Contraindication insulin treatment Treatment Glitazones , Sulphonylurea , antiplatelet drug , Thrombocytopenia &lt; 150 X109/l .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>NIDDM</keyword>
	<keyword>Platelet Activation</keyword>
	<keyword>Postprandial hyperglycemia</keyword>
	<keyword>insulin</keyword>
</DOC>